Skip to content

Edwards Lifesciences Corp

EW· NYSECore metricsCIK 1099800

Orthopedic, prosthetic & surgical appliances & supplies28 peers

Last sale
Nov 12, 2026 · +0.06%
Market cap
$60.88B
575M shares
Filings
1,074
$1.72B
Q3 2026+11.5% FY25 yoy
$307.50M
Q3 2026−74.3% FY25 yoy
$299.10M
Q3 2026−8.3% FY25 yoy
$1.07B
Q3 2026derived+360.5% FY25 yoy
$0.53
Q3 2026−73.7% FY25 yoy
$3.11B
Q3 2026−3.5% FY25 yoy
$60.88B
59.6×
9.1×
5.6×
2.34%
—

Twelve months to Sep 30, 2026 · derived

Price

$105.87+24.32%+$20.71past year
Nov 12, 2026 · IEX last sale
Figure
Range
IEX last saleClose of record

Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Financials

Revenue

$6.07BFY 2025
$6.07B0FY 2014FY 2019FY 2025
PeriodEndedValueKindSource trail
FY 20252025-12-31$6,067,600,000reported
FY 20242024-12-31$5,439,500,000reported
FY 20232023-12-31$5,010,000,000 revisedreported
FY 20222022-12-31$4,464,000,000 revisedreported
FY 20212021-12-31$5,232,500,000reported
FY 20202020-12-31$4,386,300,000reported
FY 20192019-12-31$4,348,000,000reported
FY 20182018-12-31$3,722,800,000reported
FY 20172017-12-31$3,435,300,000reported
FY 20162016-12-31$2,963,700,000reported
FY 20152015-12-31$2,493,700,000reported
FY 20142014-12-31$2,322,900,000reported

Capital returns

Dividends and buybacks · FY2016 to FY2025
Fiscal yearDividendsBuybacksTotalPer shareSharesShares · yoyof free cash flow
FY2025—$893.40M$893.40M—580.80M sh−1.2%66.9%
FY2024—$1.16B$1.16B—587.90M sh−2.2%399.9%
FY2023—$879.60M$879.60M—601.30M sh−1.2%136.8%
FY2022—$1.73B$1.73B—608.31M sh−2.4%177.4%
FY2021—$512.80M$512.80M—623.21M sh−0.2%36.5%

Segments

Revenue by Segments, FY2018 to FY2025FY2018United States · FY2018 · $2.06BEurope · FY2018 · $826.40MRest of World · FY2018 · $396.00MJapan · FY2018 · $398.40MFY2019United States · FY2019 · $2.53BEurope · FY2019 · $926.10MRest of World · FY2019 · $433.30MJapan · FY2019 · $441.40MFY2020United States · FY2020 · $2.52BEurope · FY2020 · $945.20MRest of World · FY2020 · $451.50MJapan · FY2020 · $448.60MFY2021United States · FY2021 · $2.96BEurope · FY2021 · $1.10BRest of World · FY2021 · $533.20MJapan · FY2021 · $528.00MFY2022United States · FY2022 · $2.63BEurope · FY2022 · $1.04BRest of World · FY2022 · $436.00MJapan · FY2022 · $359.50MFY2023United States · FY2023 · $2.95BEurope · FY2023 · $1.18BRest of World · FY2023 · $531.10MJapan · FY2023 · $350.80MFY2024United States · FY2024 · $3.21BEurope · FY2024 · $1.32BRest of World · FY2024 · $572.00MJapan · FY2024 · $339.80MFY2025United States · FY2025 · $3.54BEurope · FY2025 · $1.52BRest of World · FY2025 · $652.30MJapan · FY2025 · $354.70M
LineFY2025ShareChange
United States$3.54B58%+10.5%
Europe$1.52B25%+14.8%
Rest of World$652.30M11%+14.0%
Japan$354.70M5.8%+4.4%
Total$6.07B

From the 10-K filed Feb 25, 2026EW

Orthopedic, prosthetic & surgical appliances & supplies

Edwards Lifesciences Corp is the 4th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 3842

Peers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.

Edwards Lifesciences Corp · CIK 1099800 · Engraved from SEC EDGAR